BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29544578)

  • 1. Anisometropia and Refractive Status in Children with Bilateral Congenital Nasolacrimal Duct Obstruction.
    Siddiqui SN; Hannan A; Mansoor H; Asif M; Wakeel U
    J Coll Physicians Surg Pak; 2018 Mar; 28(3):210-213. PubMed ID: 29544578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Anisometropia and Refractive Status in Children With Unilateral and Bilateral Congenital Nasolacrimal Duct Obstruction.
    Siddiqui SN; Mansoor H; Asif M; Wakeel U; Saleem AA
    J Pediatr Ophthalmol Strabismus; 2016 May; 53(3):168-72. PubMed ID: 27224951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anisometropia and refractive status in children with congenital nasolacrimal duct obstruction-a prospective observational study.
    Hareendran H; Allapitchai F; Ravindran M; Shukul K; Rengappa R
    J AAPOS; 2022 Apr; 26(2):76.e1-76.e4. PubMed ID: 35314316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
    Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anisometropia and refractive status in children with unilateral congenital nasolacrimal duct obstruction.
    Saleem AA; Siddiqui SN; Wakeel U; Asif M
    Taiwan J Ophthalmol; 2018; 8(1):31-35. PubMed ID: 29675347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amblyopia risk factors in congenital nasolacrimal duct obstruction: A longitudinal case-control study.
    Yoo Y; Yang HK; Kim N; Choung HK; Hwang JM; Khwarg SI
    PLoS One; 2019; 14(6):e0217802. PubMed ID: 31194774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal dacryostenosis as a risk factor for anisometropia.
    Piotrowski JT; Diehl NN; Mohney BG
    Arch Ophthalmol; 2010 Sep; 128(9):1166-9. PubMed ID: 20837801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amblyopia Risk Factors in Newborns With Congenital Nasolacrimal Duct Obstruction.
    Vagge A; Tulumello C; Pellegrini M; Di Maita M; Iester M; Traverso CE
    J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):39-43. PubMed ID: 31972039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of amblyopia in children undergoing nasolacrimal duct irrigation and probing.
    Ozgur OR; Sayman IB; Oral Y; Akmaz B
    Indian J Ophthalmol; 2013 Dec; 61(12):698-700. PubMed ID: 24413822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous Resolution and Timing of Intervention in Congenital Nasolacrimal Duct Obstruction.
    Sathiamoorthi S; Frank RD; Mohney BG
    JAMA Ophthalmol; 2018 Nov; 136(11):1281-1286. PubMed ID: 30178001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractive state in children with unilateral congenital nasolacrimal duct obstruction.
    Bagheri A; Safapoor S; Yazdani S; Yaseri M
    J Ophthalmic Vis Res; 2012 Oct; 7(4):310-5. PubMed ID: 23503710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral Congenital Nasolacrimal Duct Obstruction, Is It An Amblyogenic Factor?
    AlHammad F; Al Tamimi E; Yassin S; AlBadri K; AlJarudi S; AlShawaf M; Khandekar R
    Middle East Afr J Ophthalmol; 2018; 25(3-4):156-160. PubMed ID: 30765954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amblyopia risk factors in infants with congenital nasolacrimal duct obstruction.
    Kim JW; Lee H; Chang M; Park M; Lee TS; Baek S
    J Craniofac Surg; 2013 Jul; 24(4):1123-5. PubMed ID: 23851753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital nasolacrimal duct obstruction in premature children.
    Lorena SH; Silva JA; Scarpi MJ
    J Pediatr Ophthalmol Strabismus; 2013; 50(4):239-44. PubMed ID: 23614467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anisometropia and Amblyopia Outcomes in Early Versus Late Resolution of Congenital Nasolacrimal Duct Obstruction in Older Infants.
    Sims DT; Gillette TB; Lam JG; Liu D; Lee C; Ding L; Tarczy-Hornoch K; Cabrera MT
    Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):39-42. PubMed ID: 38241617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasolacrimal duct obstruction: Does it really increase the risk of amblyopia in children?
    Ramkumar VA; Agarkar S; Mukherjee B
    Indian J Ophthalmol; 2016 Jul; 64(7):496-9. PubMed ID: 27609160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-existing lacrimal drainage anomalies in eyes with congenital Glaucoma.
    Senthil S; Ali MJ; Chary R; Mandal AK
    Eur J Ophthalmol; 2022 Sep; 32(5):2683-2687. PubMed ID: 35018871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital nasolacrimal duct obstruction: common management policies among pediatric ophthalmologists.
    Dotan G; Nelson LB
    J Pediatr Ophthalmol Strabismus; 2015; 52(1):14-9. PubMed ID: 25365513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anisometropia and amblyopia in nasolacrimal duct obstruction.
    Kipp MA; Kipp MA; Struthers W
    J AAPOS; 2013 Jun; 17(3):235-8. PubMed ID: 23602456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction.
    Matta NS; Singman EL; Silbert DI
    J AAPOS; 2010 Oct; 14(5):386-8. PubMed ID: 21035062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.